The overall objective and goals of the Stanford NAMSED CRC Administrative Core A are to manage, coordinate, and supervise all Center activities to effectively and optimally support the Program's goals to develop alternative model systems for enteric diseases. The Administrative Core A will be led by Dr. Calvin Kuo and Dr. Manuel Amieva as Co-Core Leaders and will involve the other Project and Core Leaders on a Center Steering Committee to monitor progress toward the Specific Aims, which are to: 1) Implement administrative & leadership mechanisms via a management plan that will facilitate communication and cooperation among the Stanford project and core leaders and with the greater NAMSED Consortium and investigators at other institutions to ensure a maximally productive research effort; 2) Monitor the progress of each of the Research and pilot projects and their interactions with the scientific cores, and to promote effective communications among them; 3) Provide an efficient, centralized unit for the fiscal and administrative operation of the NAMSED CRC activities; 4) Solicit and evaluate proposals on an annual basis in the Stanford research community for Pilot Developmental Research Projects (DRPs), and to monitor their progress. 5) Provide infrastructure support for Stanford NAMSED CRC investigators to develop collaborative studies with other members of the NAMSED Consortium.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI116484-05
Application #
9656065
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
2021-02-28
Budget Start
2019-03-01
Budget End
2020-02-28
Support Year
5
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Wosen, Jonathan E; Mukhopadhyay, Dhriti; Macaubas, Claudia et al. (2018) Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts. Front Immunol 9:2144
Hartmann, Felix J; Simonds, Erin F; Bendall, Sean C (2018) A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis. Sci Rep 8:10770
Ding, Siyuan; Zhu, Shu; Ren, Lili et al. (2018) Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells. Elife 7:
Haugh, Matthew G; Vaughan, Ted J; Madl, Christopher M et al. (2018) Investigating the interplay between substrate stiffness and ligand chemistry in directing mesenchymal stem cell differentiation within 3D macro-porous substrates. Biomaterials 171:23-33
Keren, Leeat; Bosse, Marc; Marquez, Diana et al. (2018) A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell 174:1373-1387.e19
LeSavage, Bauer L; Suhar, Nicholas A; Madl, Christopher M et al. (2018) Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D. J Vis Exp :
Madl, Christopher M; Heilshorn, Sarah C; Blau, Helen M (2018) Bioengineering strategies to accelerate stem cell therapeutics. Nature 557:335-342
Nair, Nitya; Feng, Ningguo; Blum, Lisa K et al. (2017) VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci Transl Med 9:
Dubbin, Karen; Tabet, Anthony; Heilshorn, Sarah C (2017) Quantitative criteria to benchmark new and existing bio-inks for cell compatibility. Biofabrication 9:044102
Janda, Claudia Y; Dang, Luke T; You, Changjiang et al. (2017) Surrogate Wnt agonists that phenocopy canonical Wnt and ?-catenin signalling. Nature 545:234-237

Showing the most recent 10 out of 31 publications